Previous 10 | Next 10 |
Conference Call Scheduled for Monday, February 28, 2022 at 4:30 p.m. ET. Revance Therapeutics, Inc. (Nasdaq: RVNC), a commercial stage biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that the company will release fourth quarte...
SAN FRANCISCO, CA / ACCESSWIRE / February 7, 2022 / Hagens Berman urges Revance Therapeutics, Inc. (NASDAQ:RVNC) investors to with significant losses to submit your losses now . Class Period: Nov. 25, 2019 - Oct. 11, 2021 Lead Plaintiff Deadline: Feb. 8, 2022 Visit: www.hbsslaw.co...
Radnor, Pennsylvania--(Newsfile Corp. - February 3, 2022) - The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed against Revance Therapeutics, Inc. ("Revance") (NASDAQ: RVNC). The action charges ...
SAN FRANCISCO, CA / ACCESSWIRE / February 2, 2022 / Hagens Berman urges Revance Therapeutics, Inc. (NASDAQ:RVNC) investors to with significant losses to submit your losses now . Class Period: Nov. 25, 2019 - Oct. 11, 2021 Lead Plaintiff Deadline: Feb. 8, 2022 Visit: www.hbsslaw.co...
SAN FRANCISCO, CA / ACCESSWIRE / January 25, 2022 / Hagens Berman urges Revance Therapeutics, Inc. (NASDAQ:RVNC) investors to with significant losses to submit your losses now . Class Period: Nov. 25, 2019 - Oct. 11, 2021 Lead Plaintiff Deadline: Feb. 8, 2022 Visit: www.hbsslaw....
Complete response requires qualification of new working cell bank (WCB), which is in progress The FDA stated that a reinspection of the company’s manufacturing facility will be necessary prior to approval Revance Therapeutics, Inc. (Nasdaq: RVNC), a commer...
Preliminary unaudited Q4 RHA® Collection revenue of between $23.0 million and $24.0 million Preliminary unaudited cash, cash equivalents, and short-term investments of approximately $225 million as of December 31 Preliminary unaudited full year GAAP and Non-...
RVNC DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP - Important LP February 8, 2022 Deadline Reminder for Revance Therapeutics, Inc. RVNC DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP - Important LP February 8, 2022 Deadline Reminder for Revance Therapeuti...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips SmileDirect Club (NASDAQ: SDC ) stock is built around orthodontic services using clear plastic retainers. It’s a growing market. Source: Helen89 / Shutterstock.com SmileDirect showed it was no longer grow...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Revance Therapeutics To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - December 13, 2021) - Faruqi & Faruqi, LLP, a leading national securi...
News, Short Squeeze, Breakout and More Instantly...
Revance Therapeutics Inc. Company Name:
RVNC Stock Symbol:
NASDAQ Market:
Revance Therapeutics Inc. Website:
- Total net product revenue (DAXXIFY® and RHA® Collection) of $51.7 million, a YoY increase of 13%. - DAXXIFY® net revenue of $22.1 million, after a reduction of $2.0 million related to a consumer coupon program. - Toxin market share increased from 3.0% in Q4’23 to 3...
Conference Call Scheduled for Thursday, May 9, 2024 at 4:30 p.m. ET. Revance Therapeutics, Inc. (NASDAQ: RVNC), today announced that the company will release first quarter 2024 financial results on Thursday, May 9, 2024, after the close of market. Revance will host a corresponding confe...